Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Tuberc Lung Dis ; 19(9): 1039-44, i-v, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26260821

RESUMO

SETTING: Nine months of daily isoniazid (9H) and 3 months of once-weekly rifapentine plus isoniazid (3HP) are recommended treatments for latent tuberculous infection (LTBI). The risk profile for 3HP and the contribution of hepatitis C virus (HCV) infection to hepatotoxicity are unclear. OBJECTIVES: To evaluate the hepatotoxicity risk associated with 3HP compared to 9H, and factors associated with hepatotoxicity. DESIGN: Hepatotoxicity was defined as aspartate aminotransferase (AST) >3 times the upper limit of normal (ULN) with symptoms (nausea, vomiting, jaundice, or fatigue), or AST >5 x ULN. We analyzed risk factors among adults who took at least 1 dose of their assigned treatment. A nested case-control study assessed the role of HCV. RESULTS: Of 6862 participants, 77 (1.1%) developed hepatotoxicity; 52 (0.8%) were symptomatic; 1.8% (61/3317) were on 9H and 0.4% (15/3545) were on 3HP (P < 0.0001). Risk factors for hepatotoxicity were age, female sex, white race, non-Hispanic ethnicity, decreased body mass index, elevated baseline AST, and 9H. In the case-control study, HCV infection was associated with hepatotoxicity when controlling for other factors. CONCLUSION: The risk of hepatotoxicity during LTBI treatment with 3HP was lower than the risk with 9H. HCV and elevated baseline AST were risk factors for hepatotoxicity. For persons with these risk factors, 3HP may be preferred.


Assuntos
Antituberculosos/administração & dosagem , Doença Hepática Induzida por Substâncias e Drogas , Isoniazida/administração & dosagem , Tuberculose Latente/tratamento farmacológico , Rifampina/análogos & derivados , Adulto , Antituberculosos/efeitos adversos , Aspartato Aminotransferases/sangue , Brasil , Canadá , Estudos de Casos e Controles , Esquema de Medicação , Quimioterapia Combinada , Feminino , Hepatite C/complicações , Humanos , Isoniazida/efeitos adversos , Tuberculose Latente/complicações , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Rifampina/administração & dosagem , Rifampina/efeitos adversos , Fatores de Risco , Espanha , Estados Unidos
2.
Phys Rev E Stat Nonlin Soft Matter Phys ; 80(5 Pt 1): 051111, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20364951

RESUMO

It is possible in principle to probe the many-atom potential surface using density functional theory (DFT). This will allow us to apply DFT to the Hamiltonian formulation of atomic motion in monatomic liquids by Wallace [Phys. Rev. E 56, 4179 (1997)]. For a monatomic system, analysis of the potential surface is facilitated by the random and symmetric classification of potential-energy valleys. Since the random valleys are numerically dominant and uniform in their macroscopic potential properties, only a few quenches are necessary to establish these properties. Here we describe an efficient technique for doing this. Quenches are done from easily generated "stochastic" configurations, in which the nuclei are distributed uniformly within a constraint limiting the closeness of approach. For metallic Na with atomic pair potential interactions, it is shown that quenches from stochastic configurations and quenches from equilibrium liquid molecular dynamics configurations produce statistically identical distributions of the structural potential energy. Again for metallic Na, it is shown that DFT quenches from stochastic configurations provide the parameters which calibrate the Hamiltonian. A statistical mechanical analysis shows how the underlying potential properties can be extracted from the distributions found in quenches from stochastic configurations.


Assuntos
Transferência de Energia , Modelos Químicos , Modelos Estatísticos , Sódio/química , Soluções/química , Processos Estocásticos , Simulação por Computador
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA